Free tool
FAERS Monitor: Motrin Migraine Pain
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019012 or its brand name (Motrin Migraine Pain, Ibuprofen). Reports on generic versions are filed under their own applications.
Reports
204,237
Serious
147,624
72% of reports
Hospitalization
71,962
Death reported
16,517
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective16,234
- pain15,332
- fatigue14,852
- nausea13,890
- headache12,362
- arthralgia11,136
- dyspnoea10,768
- vomiting10,215
- diarrhoea9,998
- rash9,216
- off label use8,901
- dizziness8,394
- pruritus8,097
- pyrexia8,005
- acute kidney injury6,767
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,624 |
| 2005 | 2,146 |
| 2006 | 2,063 |
| 2007 | 2,132 |
| 2008 | 1,796 |
| 2009 | 2,780 |
| 2010 | 4,073 |
| 2011 | 5,736 |
| 2012 | 7,117 |
| 2013 | 6,888 |
| 2014 | 6,624 |
| 2015 | 9,398 |
| 2016 | 12,803 |
| 2017 | 11,574 |
| 2018 | 15,839 |
| 2019 | 16,886 |
| 2020 | 15,651 |
| 2021 | 15,408 |
| 2022 | 14,826 |
| 2023 | 13,927 |
| 2024 | 12,845 |
| 2025 | 12,993 |
| 2026 | 9,099 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,849,922 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 6,767 | 4.7 | 4.6 | 19,087 |
| arthralgiaSignal | 11,136 | 2.8 | 2.8 | 12,855 |
| painSignal | 15,332 | 2.6 | 2.6 | 15,300 |
| pyrexiaSignal | 8,005 | 2.4 | 2.4 | 6,592 |
| vomitingSignal | 10,215 | 2.3 | 2.2 | 7,220 |
| rashSignal | 9,216 | 2.2 | 2.2 | 6,048 |
| pruritusSignal | 8,097 | 2.2 | 2.1 | 5,251 |
| headacheSignal | 12,362 | 2.1 | 2.0 | 6,729 |
| fatigue | 14,852 | 2.0 | 2.0 | 7,374 |
| dyspnoea | 10,768 | 2.0 | 1.9 | 5,244 |
| nausea | 13,890 | 1.8 | 1.8 | 5,255 |
| dizziness | 8,394 | 1.7 | 1.7 | 2,692 |
| diarrhoea | 9,998 | 1.6 | 1.6 | 2,312 |
| drug ineffective | 16,234 | 1.3 | 1.3 | 994 |
| off label use | 8,901 | 1.0 | 1.0 | 20 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.